Propranolol targets the contractility of infantile haemangioma-derived pericytes

British Journal of Dermatology

Volumn 171, Issue 5, 2014, Pages 1129-1137

  Lee, D ^a   Boscolo, E ^a,b   Durham, J T ^c   Mulliken, J B ^a,b   Herman, I M ^c   Bischoff, J ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; MESSENGER RNA; PROPRANOLOL; RETINAL; SILICONE; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER; BLOOD VESSEL; CAPILLARY HEMANGIOMA; CELL PROLIFERATION; CONTROLLED STUDY; DRUG TARGETING; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PERICYTE; SMOOTH MUSCLE FIBER; ANIMAL; BLOOD VOLUME; CANCER STEM CELL; CANCER TRANSPLANTATION; DRUG EFFECTS; HEMANGIOMA; METABOLISM; NUDE MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZATION; TUMOR CELL CULTURE; VASCULARIZATION; VASOCONSTRICTION; XENOGRAFT;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BLOOD VOLUME; CELL PROLIFERATION; ENDOTHELIAL CELLS; EPINEPHRINE; HEMANGIOMA; HUMANS; MALE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; PERICYTES; PROPRANOLOL; RANDOM ALLOCATION; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 84911453647     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.13048     Document Type: Article

References (29)

1. Luu M, Frieden IJ,. Haemangioma: clinical course, complications and management. Br J Dermatol 2013; 169: 20-30.
2. Leaute-Labreze C, Dumas de la Roque E, Hubiche T, et al,. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008; 358: 2649-51.
3. Bagazgoitia L, Hernandez-Martin A, Torrelo A,. Recurrence of infantile hemangiomas treated with propranolol. Pediatr Dermatol 2011; 28: 658-62.
4. Causse S, Aubert H, Saint-Jean M, et al,. Propranolol-resistant infantile haemangiomas. Br J Dermatol 2013; 169: 125-9.
5. Storch CH, Hoeger PH,. Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action. Br J Dermatol 2010; 163: 269-74.
6. Bingham MM, Saltzman B, Vo NJ, et al,. Propranolol reduces infantile hemangioma volume and vessel density. Otolaryngol Head Neck Surg 2012; 147: 338-44.
7. Fredriksson JM, Lindquist JM, Bronnikov GE, et al,. Norepinephrine induces vascular endothelial growth factor gene expression in brown adipocytes through a beta-adrenoreceptor/cAMP/protein kinase A pathway involving Src but independently of Erk1/2. J Biol Chem 2000; 275: 13802-11.
8. Chisholm KM, Chang KW, Truong MT, et al,. β-Adrenergic receptor expression in vascular tumors. Mod Pathol 2012; 25: 1446-51.
9. Hadaschik E, Scheiba N, Engstner M, et al,. High levels of β2-adrenoceptors are expressed in infantile capillary hemangiomas and may mediate the therapeutic effect of propranolol. J Cutan Pathol 2012; 39: 881-3.
10. Rossler J, Haubold M, Gilsbach R, et al,. beta1-Adrenoceptor mRNA level reveals distinctions between infantile hemangioma and vascular malformations. Pediatr Res 2013; 73: 409-13.
11. Ji Y, Chen S, Li K, et al,. The role of β-adrenergic receptor signaling in the proliferation of hemangioma-derived endothelial cells. Cell Div 2013; 8: 1.
12. Wong A, Hardy KL, Kitajewski AM, et al,. Propranolol accelerates adipogenesis in hemangioma stem cells and causes apoptosis of hemangioma endothelial cells. Plast Reconstr Surg 2012; 130: 1012-21.
13. Chim H, Armijo BS, Miller E, et al,. Propranolol induces regression of hemangioma cells through HIF-1alpha-mediated inhibition of VEGF-A. Ann Surg 2012; 256: 146-56.
14. Ji Y, Li K, Xiao X, et al,. Effects of propranolol on the proliferation and apoptosis of hemangioma-derived endothelial cells. J Pediatr Surg 2012; 47: 2216-23.
15. Stiles J, Amaya C, Pham R, et al,. Propranolol treatment of infantile hemangioma endothelial cells: a molecular analysis. Exp Ther Med 2012; 4: 594-604.
16. Varma DR, Shen H, Deng XF, et al,. Inverse agonist activities of beta-adrenoceptor antagonists in rat myocardium. Br J Pharmacol 1999; 127: 895-902.
17. Baker JG, Hall IP, Hill SJ,. Agonist and inverse agonist actions of beta-blockers at the human beta 2-adrenoceptor provide evidence for agonist-directed signaling. Mol Pharmacol 2003; 64: 1357-69.
18. Boscolo E, Mulliken JB, Bischoff J,. Pericytes from infantile hemangioma display proangiogenic properties and dysregulated angiopoietin-1. Arterioscler Thromb Vasc Biol 2013; 33: 501-9.
19. Smadja DM, Mulliken JB, Bischoff J,. E-selectin mediates stem cell adhesion and formation of blood vessels in a murine model of infantile hemangioma. Am J Pathol 2012; 181: 2239-47.
20. Khan ZA, Boscolo E, Picard A, et al,. Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice. J Clin Invest 2008; 118: 2592-9.
21. Kraling BM, Bischoff J,. A simplified method for growth of human microvascular endothelial cells results in decreased senescence and continued responsiveness to cytokines and growth factors. In Vitro Cell Dev Biol Anim 1998; 34: 308-15.
22. Kotecki M, Zeiger AS, Van Vliet KJ, et al,. Calpain- and talin-dependent control of microvascular pericyte contractility and cellular stiffness. Microvasc Res 2010; 80: 339-48.
23. Kelley C, D'Amore P, Hechtman HB, et al,. Microvascular pericyte contractility in vitro: comparison with other cells of the vascular wall. J Cell Biol 1987; 104: 483-90.
24. Markhotina N, Liu GJ, Martin DK,. Contractility of retinal pericytes grown on silicone elastomer substrates is through a protein kinase A-mediated intracellular pathway in response to vasoactive peptides. IET Nanobiotechnol 2007; 1: 44-51.
25. Allen P, Melero-Martin J, Bischoff J,. Type I collagen, fibrin and PuraMatrix matrices provide permissive environments for human endothelial and mesenchymal progenitor cells to form neovascular networks. J Tissue Eng Regen Med 2011; 5: e74-86.
26. Kang KT, Allen P, Bischoff J,. Bioengineered human vascular networks transplanted into secondary mice reconnect with the host vasculature and re-establish perfusion. Blood 2011; 118: 6718-21.
27. Kelley C, D'Amore P, Hechtman HB, et al,. Vasoactive hormones and cAMP affect pericyte contraction and stress fibres in vitro. J Muscle Res Cell Motil 1988; 9: 184-94.
28. Sun D, Huang A, Mital S, et al,. Norepinephrine elicits beta2-receptor-mediated dilation of isolated human coronary arterioles. Circulation 2002; 106: 550-5.
29. Boscolo E, Stewart CL, Greenberger S, et al,. JAGGED1 signaling regulates hemangioma stem cell-to-pericyte/vascular smooth muscle cell differentiation. Arterioscler Thromb Vasc Biol 2011; 31: 2181-92.